SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001250853-21-000083
Filing Date
2021-08-30
Accepted
2021-08-30 14:35:17
Documents
1
Period of Report
2021-08-27

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4  
1 PRIMARY DOCUMENT primary_doc.xml 4 4346
  Complete submission text file 0001250853-21-000083.txt   5703
Mailing Address 1555 BAYSHORE HIGHWAY, SUITE 200 BURLINGAME CA 94010
Business Address 1555 BAYSHORE HIGHWAY, SUITE 200 BURLINGAME CA 94010 650-701-7901
Kindred Biosciences, Inc. (Issuer) CIK: 0001561743 (see all company filings)

IRS No.: 461160142 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 2050 W. 190TH STREET SUITE 400 TORRANCE CA 90504
Business Address
Liu Nanxi (Reporting) CIK: 0001818497 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36225 | Film No.: 211222768